Drug-induced extrapyramidal symptoms. A cooperative study.
D000928:Antidepressive Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002090:Butyrophenones / Q000009:adverse effects; D002746:Chlorpromazine / Q000009:adverse effects; D004357:Drug Synergism; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D009069:Movement Disorders / Q000139:chemically induced*; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011346:Prochlorperazine / Q000009:adverse effects; D014268:Trifluoperazine / Q000009:adverse effects
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002090:Butyrophenones; D014268:Trifluoperazine; D002746:Chlorpromazine; D011241:Prednisone; D011346:Prochlorperazine